NCT00033605View on ClinicalTrials.gov

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

PHASE3CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Cervical CancerColorectal CancerDiarrheaEndometrial CancerFallopian Tube CancerOvarian CancerProstate CancerSarcomaUnspecified Adult Solid Tumor, Protocol SpecificVaginal CancerVulvar Cancer

Interventions

DRUG

octreotide acetate

OTHER

placebo

RADIATION

radiation

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00033605 - Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | Biotech Hunter | Biotech Hunter